CA2494660A1 - Use of carboxamides for the treatment of tinnitus - Google Patents

Use of carboxamides for the treatment of tinnitus Download PDF

Info

Publication number
CA2494660A1
CA2494660A1 CA002494660A CA2494660A CA2494660A1 CA 2494660 A1 CA2494660 A1 CA 2494660A1 CA 002494660 A CA002494660 A CA 002494660A CA 2494660 A CA2494660 A CA 2494660A CA 2494660 A1 CA2494660 A1 CA 2494660A1
Authority
CA
Canada
Prior art keywords
compound
formula
tinnitus
treatment
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002494660A
Other languages
English (en)
French (fr)
Inventor
Markus Schmutz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0218244A external-priority patent/GB0218244D0/en
Priority claimed from GB0218243A external-priority patent/GB0218243D0/en
Application filed by Individual filed Critical Individual
Publication of CA2494660A1 publication Critical patent/CA2494660A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CA002494660A 2002-08-06 2003-08-05 Use of carboxamides for the treatment of tinnitus Abandoned CA2494660A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB0218243.4 2002-08-06
GB0218244A GB0218244D0 (en) 2002-08-06 2002-08-06 Organic compounds
GB0218243A GB0218243D0 (en) 2002-08-06 2002-08-06 Organic compounds
GB0218244.2 2002-08-06
PCT/EP2003/008669 WO2004014391A1 (en) 2002-08-06 2003-08-05 Use of carboxamides for the treatment of tinnitus

Publications (1)

Publication Number Publication Date
CA2494660A1 true CA2494660A1 (en) 2004-02-19

Family

ID=31716915

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002494660A Abandoned CA2494660A1 (en) 2002-08-06 2003-08-05 Use of carboxamides for the treatment of tinnitus

Country Status (8)

Country Link
US (1) US7465723B2 (https=)
EP (1) EP1528927A1 (https=)
JP (1) JP2005538126A (https=)
CN (1) CN1674909A (https=)
AU (1) AU2003266965A1 (https=)
BR (1) BR0313230A (https=)
CA (1) CA2494660A1 (https=)
WO (1) WO2004014391A1 (https=)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9763954B2 (en) 2007-01-15 2017-09-19 Bial—Portela & Ca, S.A. Therapeutical uses of eslicarbazepine
US10675287B2 (en) 2005-05-06 2020-06-09 Bial-Portela & Ca S.A. Methods of treatment of partial onset seizures using eslicarbazepine acetate

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0303615D0 (en) * 2003-02-17 2003-03-19 Novartis Ag Use of organic compounds
AR048318A1 (es) * 2004-03-22 2006-04-19 Novartis Ag Formulaciones de matriz orales que comprenden licarbazepina
EP1879590A1 (en) * 2005-05-06 2008-01-23 Portela & Ca., S.A. Eslicarbazepine acetate and methods of use
US9410427B2 (en) * 2012-06-05 2016-08-09 United Technologies Corporation Compressor power and torque transmitting hub
US8920855B1 (en) 2012-10-30 2014-12-30 Setem Hemth, Inc Methods of topically treating tinnitus and related disorders
CN103980270A (zh) * 2014-05-19 2014-08-13 埃斯特维华义制药有限公司 一种（r）-3-奎宁醇的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5472714A (en) 1993-09-08 1995-12-05 Ciba-Geigy Corporation Double-layered oxcarbazepine tablets
PT101732B (pt) * 1995-06-30 1997-12-31 Portela & Ca Sa Novas di-hidrodibenzo<b,f>azepinas substituidas processo para a sua preparacao composicoes farmaceuticas que as contem e utilizacao dos novos compostos na preparacao de composicoes farmaceuticas empregues em doencas do sistema nervoso
IL125244A (en) 1998-07-07 2002-12-01 Yissum Res Dev Co Pharmaceutical compositions containing low-melting waxes
GB9925962D0 (en) * 1999-11-02 1999-12-29 Novartis Ag Organic compounds

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10675287B2 (en) 2005-05-06 2020-06-09 Bial-Portela & Ca S.A. Methods of treatment of partial onset seizures using eslicarbazepine acetate
US10695354B2 (en) 2005-05-06 2020-06-30 Bial-Portela & Ca S.A. Methods of treatment of partial onset seizures using eslicarbazepine acetate
US10702536B2 (en) 2005-05-06 2020-07-07 Bial-Portela & Ca S.A. Methods of treatment of partial onset seizures using eslicarbazepine acetate
US11364247B2 (en) 2005-05-06 2022-06-21 Bial-Portela & Ca S.A. Methods of treatment of partial onset seizures using eslicarbazepine acetate
US9763954B2 (en) 2007-01-15 2017-09-19 Bial—Portela & Ca, S.A. Therapeutical uses of eslicarbazepine

Also Published As

Publication number Publication date
BR0313230A (pt) 2005-07-12
EP1528927A1 (en) 2005-05-11
CN1674909A (zh) 2005-09-28
WO2004014391A1 (en) 2004-02-19
US7465723B2 (en) 2008-12-16
JP2005538126A (ja) 2005-12-15
US20060106009A1 (en) 2006-05-18
WO2004014391B1 (en) 2004-04-15
AU2003266965A1 (en) 2004-02-25

Similar Documents

Publication Publication Date Title
TWI298020B (en) Gabapentin analogues for sleep disorders
US20100120746A1 (en) Use of r-10-hydroxy-10,11-dihydro-carbamazepine in neuropathic pain
CN102512406A (zh) 用于治疗认知障碍的α-氨基酰胺衍生物
US6649607B2 (en) Compositions and methods for treating or preventing convulsions or seizures
CN112930175A (zh) 治疗癫痫的方法
EP2114864A1 (en) Alpha-halo- and alpha-alkyl-cyclopropylcarboxy compounds and uses thereof
BR0010573A (pt) Métodos de tratamento ou prevenção, em um paciente, de ansiedade, de um estado convulsivo, de espasticidade ou espasmos musculares agudos, de um distútbios afetivo de um comportamento agressivo, de vìcio de drogas ou álcool, de nìveis de hormÈnio no plasma anormais, de distúrbio do sono, de uma doença ou condição ou sintoma da mesma, em um paciente afetado pela modulação de um ou mais dos receptores de benzodiazepina centrais ou periféricos, composição farmacêutica, forma de dosagem individual de n-desmetilzopiclona, métodos para preparar n-desmetilzopiclona, e racêmica, para preparar (+), e (-) n-desmetil zopiclona, e, para aumentar a pureza óptica de zopiclona ou desmetilzopiclona
CA2494660A1 (en) Use of carboxamides for the treatment of tinnitus
US20100063029A1 (en) Use of s-10-hydroxy-10,11-dihydro-carbamazepine for the treatment of anxiety and bipolar disorders
AU2004226827B2 (en) Use of 10-hydroxy-10,11-dihydrocarbamazepine derivatives for the treatment of affective disorders
US20170105957A1 (en) Methods of Treating Ototoxicity
JPH08504828A (ja) 置換（アリールアルキルアミノベンジル）アミノプロピオンアミド誘導体及びその製造方法
CN113582911A (zh) 多靶点多奈哌齐-异羟肟酸型化合物及其制备方法和应用
FR2888748A1 (fr) Composes neuroprotecteurs et compositions pharmaceutiques les comprenant
MXPA05000979A (es) Derivados de glicina sustituidos para uso como medicamentos.
CA2373856C (en) 1-arylcycloalkyl sulphides, sulphoxides and sulphones for the treatment of drug misuse or addictive disorders
CN1747735A (zh) S－10－羟基－10,11－二氢－卡马西平在治疗焦虑和双相情感障碍中的用途
AU2007251901A1 (en) Use of S-10 hydroxy-10, 11-dihydro-carbamazepine for the treatment of anxiety and bipolar disorders
HK40045266A (en) Method for treating epilepsy

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued